Equillium, Inc. (EQ) vs Vivani Medical, Inc. (VANI)

Equillium, Inc. and Vivani Medical, Inc. are both Biotechnology companies. Equillium, Inc. and Vivani Medical, Inc. are of similar size ($111.0M and $109.1M). Equillium, Inc. grew revenue faster over the last twelve months: 13.9% against −51.0%. Across the 12 metrics below, Equillium, Inc. leads on 10 and Vivani Medical, Inc. on 2.

Valuation

Metric EQ VANI Biotechnology median
P/E n/m n/m 7.88
P/S 4.54 31.96 11.47
P/B 3.33 5.69 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3.18 26.48 10.73
Earnings yield (11.98%) (28.23%) (28.84%)
Free cash flow yield (10.75%) (24.54%) (23.03%)

Profitability

Metric EQ VANI Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) (220.40%) (57.72%)
Return on assets (50.68%) (74.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EQ VANI Biotechnology median
Revenue growth (TTM) 13.89% (51.00%) 5.64%
EPS growth (last fiscal year) (69.57%) 0.00% —
Revenue growth, 5-year CAGR — (0.11%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ VANI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 3.25 4.73
Net debt to EBITDA 1.29 0.60 0.96

Dividend

Metric EQ VANI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EQ VANI Biotechnology median
Market cap 109.06m 110.95m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack